Semnur Pharmaceuticals, Inc.
4970 El Camino Real
Los Altos
California
94022
United States
Tel: 888-315-8706
Website: http://semnurpharma.com/
About Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the clinical and commercial development of innovative products that meet the needs of pain management practitioners and their patients.Our primary focus lies in the development of injectable non-opioid products for meeting the needs of under served patients with back pain. We believe we have the technology to improve products' efficacy and safety and make a critical difference in the treatment of back pain patients.
In the United States, Semnur is planning to develop and commercialize product candidates, either through its own efforts or in conjunction with partners. Outside of the United States, Semnur anticipates commercializing these products on a worldwide basis through select regional partnerships.
5 articles about Semnur Pharmaceuticals, Inc.
-
Semnur Pharma Begins Pivotal Phase III Trial For SP-102 in Patients With Lumbar Radicular Pain/Sciatica
1/8/2018
In addition, the FDA has granted SP-102 Fast Track Designation for the treatment of lumbar radicular pain/sciatica.
-
Semnur Announces Successful Phase I/II Trial In Patients With Radicular Pain For Its Lead Product, SP-102
6/26/2017
-
Sorrento's Subsidiary Scintilla Pharma Snapped Up Semnur for $200 Million
8/16/2016
-
Semnur Files SEC Form D, Notice Of Exempt Offering Of Securities
9/3/2013
-
Back Pain Drug Developer Semnur Raises $6 Million
8/16/2013